Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Heviz – page 2

129 clinical trials in Heviz, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.

Heviz at a glance
129
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

129 trials in Heviz

Open in trial search

Study on Long-Term Safety of Ianalumab for Patients with Systemic Lupus Erythematosus

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Emtricitabine
  • Sponsor:Novartis Pharma AG

Study on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Favezelimab
  • Sponsor:Merck Sharp & Dohme LLC

Study on Cefepime and Enmetazobactam for Children with Complicated Urinary Tract Infections, Including Acute Pyelonephritis

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:0–17 years
  • Substances:Cefepime
  • Sponsor:Orchid Pharma Europe GmbH

A study of the safety and efficacy of AC01 in patients with heart failure with reduced ejection fraction

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Drocamorelin
  • Sponsor:AnaCardio AB

A Phase 2/3 Randomized Double‑Blind Study of Inebilizumab for Safety and Tolerability in Patients with Autoimmune Hepatitis

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Inebilizumab
  • Sponsor:Amgen Inc.

Efficacy and safety of ABP 938 compared with aflibercept in participants with neovascular age‑related macular degeneration

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Amgen Inc.

Effect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:AZD5004
  • Sponsor:Astrazeneca AB

Efficacy and safety of lunsekimig in adults with inadequately controlled eosinophilic COPD: a randomized, double‑blind, placebo‑controlled trial

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Lunsekimig
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Gastric cancer+1

Recruiting

Study of AZD0901 (sonesitatug vedotin) with capecitabine ± rilvegostomig in adults with advanced stomach or esophageal cancer (Claudin‑18.2‑positive, HER2‑negative)

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:AZD0901
  • Sponsor:Astrazeneca AB

A Phase 2/3 Study of intravitreal mk-8748 versus aflibercept in adults with neovascular age‑related macular degeneration

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Eyebiotech Limited

VMX-C001 in Patients Taking Factor Xa Inhibitors Who Need Urgent Surgery or an Invasive Procedure With High Bleeding Risk

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:VMX-C001
  • Sponsor:VarmX B.V.

Nipocalimab in Adults with Moderate to Severe Systemic Lupus Erythematosus

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Nipocalimab
  • Sponsor:Janssen - Cilag International

Other cities in Hungary

The busiest research cities in the country

All 73 cities in Hungary

Clinical research in Heviz

What the registry says about research in the country

01 Rheumatology Research

Clinical investigations focusing on rheumatoid arthritis treatments, comparing the effectiveness of different therapeutic approaches for patients who haven't responded adequately to conventional treatments.

  • Treatment Comparison Studies
  • Disease Management
  • Therapeutic Innovation

Research aims to evaluate new treatment options for patients with moderate to severe rheumatoid arthritis, examining both symptom management and disease progression prevention.

02 Inflammatory Conditions

Comprehensive research examining advanced therapies for inflammatory disorders, with a particular focus on autoimmune conditions affecting joint health and mobility.

  • Autoimmune Disease Research
  • Long-term Treatment Efficacy
  • Patient Response Evaluation

Studies assess the safety and effectiveness of innovative treatments compared to existing therapeutic options.

03 Treatment Optimization

Investigation of combination therapy approaches for patients who have shown inadequate response to standard treatments, exploring new pathways for enhanced therapeutic outcomes.

  • Drug Comparison Studies
  • Treatment Safety Assessment
  • Long-term Effectiveness

Research focuses on optimizing treatment strategies for patients with resistant forms of inflammatory arthritis.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.